C-SUITE

Former Forever 21, Abercrombie exec joins MedMen

BY Marianne Wilson

Fast-growing cannabis company MedMen has tapped a retail veteran to head up finance.

MedMen Enterprises Inc. announced the appointment of Michael W. Kramer as CFO, effective Dec. 10. Most recently, he served as CFO of Forever 21. Kramer also served as COO of J.C. Penney (December 2011 – April 2013), CEO and president of Kellwood Inc. (August 2008 – December 2011), and executive VP and CFO of Abercrombie & Fitch (August 2005 – August 2008) where he oversaw 12 quarters of increased year-over-year earnings, according to MedMen. He also served as CFO of Apple Retail (2000 – 2005).

“Michael’s extensive financial and operational experience in retail and tech, and his success in scaling high-growth businesses will be instrumental as MedMen moves to operationalize the balance of our footprint,” said Adam Bierman, MedMen co-founder and CEO. “His appointment underscores our commitment to investing in a strong management team with a track record of execution. Our industry and business continue to evolve, and it is paramount that we have the right talent to execute at each stage of our growth.”

Kramer’s hiring follows a number of key executive hires at MedMen in recent months, including:

• COO Ben Cook, a global supply chain executive with brands such as Apple and Sam’s Club;

• CMO David H. Dancer, a veteran marketing executive with more than 25 years of experience leading brands such as Teleflora, Charles Schwab, Visa and American Express;

• Senior VP of human resources Clarence Foster with 20 years of experience leading companies in manufacturing, automotive and consumer products for companies such as Nissan Motors and L’Oréal; and

• Chief digital officer Mike Lane with two decades of experience leading design and development of digital customer experiences at brands like Live Nation, Ticketmaster, FOX Broadcasting and Adobe.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Do you expect your business to be challenged by the ongoing escalation of the the heightened U.S.-China trade dispute?